These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

521 related articles for article (PubMed ID: 25927341)

  • 1. Methyl-CpG-binding domain proteins: readers of the epigenome.
    Du Q; Luu PL; Stirzaker C; Clark SJ
    Epigenomics; 2015; 7(6):1051-73. PubMed ID: 25927341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation-dependent and -independent genomic targeting principles of the MBD protein family.
    Baubec T; Ivánek R; Lienert F; Schübeler D
    Cell; 2013 Apr; 153(2):480-92. PubMed ID: 23582333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Methyl-CpG-binding proteins. Targeting specific gene repression.
    Ballestar E; Wolffe AP
    Eur J Biochem; 2001 Jan; 268(1):1-6. PubMed ID: 11121095
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methyl CpG-binding proteins and transcriptional repression.
    Wade PA
    Bioessays; 2001 Dec; 23(12):1131-7. PubMed ID: 11746232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Recruitment of MBD1 to target genes requires sequence-specific interaction of the MBD domain with methylated DNA.
    Clouaire T; de Las Heras JI; Merusi C; Stancheva I
    Nucleic Acids Res; 2010 Aug; 38(14):4620-34. PubMed ID: 20378711
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer.
    Stirzaker C; Song JZ; Ng W; Du Q; Armstrong NJ; Locke WJ; Statham AL; French H; Pidsley R; Valdes-Mora F; Zotenko E; Clark SJ
    Oncogene; 2017 Mar; 36(10):1328-1338. PubMed ID: 27593931
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MBD3L2 interacts with MBD3 and components of the NuRD complex and can oppose MBD2-MeCP1-mediated methylation silencing.
    Jin SG; Jiang CL; Rauch T; Li H; Pfeifer GP
    J Biol Chem; 2005 Apr; 280(13):12700-9. PubMed ID: 15701600
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural analyses reveal that MBD3 is a methylated CG binder.
    Liu K; Lei M; Wu Z; Gan B; Cheng H; Li Y; Min J
    FEBS J; 2019 Aug; 286(16):3240-3254. PubMed ID: 30980593
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of transcription and chromatin by methyl-CpG binding protein MBD1.
    Nakao M; Matsui S; Yamamoto S; Okumura K; Shirakawa M; Fujita N
    Brain Dev; 2001 Dec; 23 Suppl 1():S174-6. PubMed ID: 11738867
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Methylation-mediated proviral silencing is associated with MeCP2 recruitment and localized histone H3 deacetylation.
    Lorincz MC; Schübeler D; Groudine M
    Mol Cell Biol; 2001 Dec; 21(23):7913-22. PubMed ID: 11689684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recruitment of methylated CpG binding domains by the orphan receptor GCNF initiates the repression and silencing of Oct4 expression.
    Gu P; Le Menuet D; Chung AC; Cooney AJ
    Mol Cell Biol; 2006 Dec; 26(24):9471-83. PubMed ID: 17030610
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structural basis for the ability of MBD domains to bind methyl-CG and TG sites in DNA.
    Liu K; Xu C; Lei M; Yang A; Loppnau P; Hughes TR; Min J
    J Biol Chem; 2018 May; 293(19):7344-7354. PubMed ID: 29567833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MBD3L1 is a transcriptional repressor that interacts with methyl-CpG-binding protein 2 (MBD2) and components of the NuRD complex.
    Jiang CL; Jin SG; Pfeifer GP
    J Biol Chem; 2004 Dec; 279(50):52456-64. PubMed ID: 15456747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG and methylation-dependent DNA binding and dynamics of the methylcytosine binding domain 2 protein at the single-molecule level.
    Pan H; Bilinovich SM; Kaur P; Riehn R; Wang H; Williams DC
    Nucleic Acids Res; 2017 Sep; 45(15):9164-9177. PubMed ID: 28637186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tagging methyl-CpG-binding domain proteins reveals different spatiotemporal expression and supports distinct functions.
    Wood KH; Johnson BS; Welsh SA; Lee JY; Cui Y; Krizman E; Brodkin ES; Blendy JA; Robinson MB; Bartolomei MS; Zhou Z
    Epigenomics; 2016 Apr; 8(4):455-73. PubMed ID: 27066839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA methylation directs genomic localization of Mbd2 and Mbd3 in embryonic stem cells.
    Hainer SJ; McCannell KN; Yu J; Ee LS; Zhu LJ; Rando OJ; Fazzio TG
    Elife; 2016 Nov; 5():. PubMed ID: 27849519
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Densely methylated DNA traps Methyl-CpG-binding domain protein 2 but permits free diffusion by Methyl-CpG-binding domain protein 3.
    Leighton GO; Irvin EM; Kaur P; Liu M; You C; Bhattaram D; Piehler J; Riehn R; Wang H; Pan H; Williams DC
    J Biol Chem; 2022 Oct; 298(10):102428. PubMed ID: 36037972
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preferential binding of the methyl-CpG binding domain protein 2 at methylated transcriptional start site regions.
    Chatagnon A; Perriaud L; Nazaret N; Croze S; Benhattar J; Lachuer J; Dante R
    Epigenetics; 2011 Nov; 6(11):1295-307. PubMed ID: 22048253
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An epigenetic regulator: methyl-CpG-binding domain protein 1 (MBD1).
    Li L; Chen BF; Chan WY
    Int J Mol Sci; 2015 Mar; 16(3):5125-40. PubMed ID: 25751725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Engineering a high-affinity methyl-CpG-binding protein.
    Jørgensen HF; Adie K; Chaubert P; Bird AP
    Nucleic Acids Res; 2006 Aug; 34(13):e96. PubMed ID: 16893950
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 27.